YU4198A - Karbapenem antibiotik, kompozicija i postupak za dobijanje - Google Patents

Karbapenem antibiotik, kompozicija i postupak za dobijanje

Info

Publication number
YU4198A
YU4198A YU4198A YU4198A YU4198A YU 4198 A YU4198 A YU 4198A YU 4198 A YU4198 A YU 4198A YU 4198 A YU4198 A YU 4198A YU 4198 A YU4198 A YU 4198A
Authority
YU
Yugoslavia
Prior art keywords
composition
preparation
carbapenem antibiotic
carbapenem
antibiotic
Prior art date
Application number
YU4198A
Other languages
English (en)
Inventor
Jeffrey Zimmerman
M. John Williams
A. Paul Bergquist
M. Lisa Di Michele
C. David Dubost
J. Michael Kaufman
R. Danile Sidler
A. William Hunke
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU4198(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9612668.5A external-priority patent/GB9612668D0/en
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of YU4198A publication Critical patent/YU4198A/sh
Publication of RS49583B publication Critical patent/RS49583B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Opisana je farmaceutska kompozicija koja sadrži jedinejnje formule I ili njegovu farmaceutski prihvatljivu so, pro-lek ili hidrat, u stabilizovanom obliku i/ili u kombinaciji sa izvorom ugljen dioksida.
YUP-41/98A 1996-05-28 1997-05-23 Karbapenem antibiotik, kompozicija i postupak za dobijanje RS49583B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1851896P 1996-05-28 1996-05-28
GBGB9612668.5A GB9612668D0 (en) 1996-06-18 1996-06-18 Carbapenem antibiotic composition and method of preparation

Publications (2)

Publication Number Publication Date
YU4198A true YU4198A (sh) 1998-12-23
RS49583B RS49583B (sr) 2007-04-10

Family

ID=26309530

Country Status (34)

Country Link
EP (1) EP0863901B1 (sh)
JP (2) JPH11509871A (sh)
KR (2) KR100403497B1 (sh)
CN (1) CN1067074C (sh)
AT (1) ATE252584T1 (sh)
AU (1) AU710102B2 (sh)
BG (1) BG63821B1 (sh)
CA (1) CA2227994C (sh)
CO (1) CO4940412A1 (sh)
CY (1) CY2437B1 (sh)
CZ (1) CZ296381B6 (sh)
DE (1) DE69725696T2 (sh)
DK (1) DK0863901T3 (sh)
DZ (1) DZ2242A1 (sh)
EA (1) EA000534B1 (sh)
EE (1) EE04678B1 (sh)
ES (1) ES2208907T3 (sh)
HK (1) HK1016176A1 (sh)
HR (1) HRP970281B1 (sh)
HU (1) HU229426B1 (sh)
ID (1) ID16974A (sh)
IL (1) IL123078A (sh)
IS (1) IS2353B (sh)
MX (1) MX9800808A (sh)
NO (1) NO323815B1 (sh)
NZ (1) NZ329649A (sh)
PL (1) PL188917B1 (sh)
PT (1) PT863901E (sh)
RS (1) RS49583B (sh)
SI (1) SI0863901T1 (sh)
SK (1) SK284359B6 (sh)
TR (1) TR199800146T1 (sh)
TW (1) TW434014B (sh)
WO (1) WO1997045430A1 (sh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018800A1 (en) * 1996-10-28 1998-05-07 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
US6180783B1 (en) * 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
JP3245427B2 (ja) * 1997-06-16 2002-01-15 メルク エンド カンパニー インコーポレーテッド 安定化されたカルバペネム中間体および合成における使用
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
ES2234689T3 (es) * 1999-10-29 2005-07-01 MERCK & CO., INC. Procedimiento de preparacion de composiciones de antibioticos a base de carbapenemo.
AR035728A1 (es) 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
CN101357918B (zh) * 2007-06-22 2011-05-18 山东轩竹医药科技有限公司 含有异硫脲基巯基吡咯烷的培南衍生物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
WO2009075309A1 (ja) * 2007-12-12 2009-06-18 Dainippon Sumitomo Pharma Co., Ltd. 製剤組成物
CN101550138B (zh) * 2008-04-03 2011-05-18 山东轩竹医药科技有限公司 巯基氮杂环烷酰胺醇取代的培南衍生物
EP2505191A1 (en) * 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Lyophilized Carbapenem antibiotic composition
KR101316971B1 (ko) 2009-03-31 2013-10-11 미쓰비시마테리알덴시카세이가부시키가이샤 함불소 ｎ-알킬술포닐이미드 화합물 및 그 제조 방법, 그리고 이온성 화합물의 제조 방법
BRPI1014338B1 (pt) 2009-06-25 2019-12-24 Shell Int Research método para injetar água em uma formação contendo hidrocarbonetos, e, método para preparar uma água com salinidade elevada
US8889384B2 (en) 2010-10-07 2014-11-18 Shell Oil Company Process for the production of alcohols from biomass
PL2635712T3 (pl) 2010-11-05 2014-12-31 Shell Int Research Obróbka biomasy do wytworzenia materiałów użytecznych do biopaliw
WO2012088108A1 (en) 2010-12-20 2012-06-28 Shell Oil Company Process for the production of alcohols from biomass
EP2791344B1 (en) 2011-12-15 2016-02-24 Shell Internationale Research Maatschappij B.V. Method of treating byproducts from ethanol production
EP2850171B1 (en) 2012-05-17 2022-07-27 Shell Internationale Research Maatschappij B.V. Methods for processing biomass material
CN103860485A (zh) * 2012-12-18 2014-06-18 深圳市海滨制药有限公司 一种厄他培南钠冻干制剂及其制备方法
EP3132045A1 (en) 2014-04-17 2017-02-22 Shell Internationale Research Maatschappij B.V. Processes for producing fermentation products
EP3180320B1 (en) 2014-08-14 2021-01-13 Shell International Research Maatschappij B.V. Process for preparing furfural from biomass

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8502863A1 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds

Also Published As

Publication number Publication date
IL123078A (en) 2002-03-10
ATE252584T1 (de) 2003-11-15
CO4940412A1 (es) 2000-07-24
IS4663A (is) 1998-01-27
PL188917B1 (pl) 2005-05-31
CZ25398A3 (cs) 1998-07-15
EE04678B1 (et) 2006-08-15
CA2227994C (en) 2002-06-25
CN1198162A (zh) 1998-11-04
EP0863901A1 (en) 1998-09-16
EE9800022A (et) 1998-08-17
HRP970281B1 (en) 2002-04-30
JP5255983B2 (ja) 2013-08-07
AU710102B2 (en) 1999-09-16
CY2437B1 (en) 2004-11-12
RS49583B (sr) 2007-04-10
DE69725696D1 (de) 2003-11-27
CN1067074C (zh) 2001-06-13
KR100403497B1 (ko) 2003-10-30
BG102273A (bg) 1998-09-30
IS2353B (is) 2008-04-15
TW434014B (en) 2001-05-16
KR100344479B1 (ko) 2002-10-31
SK10998A3 (en) 1998-08-05
HRP970281A2 (en) 1998-06-30
PT863901E (pt) 2004-02-27
WO1997045430A1 (en) 1997-12-04
KR19990036052A (sh) 1999-05-25
HUP9901567A2 (hu) 1999-09-28
HU229426B1 (en) 2013-12-30
HK1016176A1 (en) 1999-10-29
ID16974A (id) 1997-11-27
SI0863901T1 (en) 2004-04-30
IL123078A0 (en) 1998-09-24
AU3077597A (en) 1998-01-05
EP0863901B1 (en) 2003-10-22
JPH11509871A (ja) 1999-08-31
CA2227994A1 (en) 1997-12-04
NO323815B1 (no) 2007-07-09
DK0863901T3 (da) 2004-02-16
DZ2242A1 (fr) 2002-12-18
CZ296381B6 (cs) 2006-03-15
EA199800180A1 (ru) 1998-08-27
MX9800808A (es) 1998-04-30
HUP9901567A3 (en) 2000-03-28
BG63821B1 (bg) 2003-02-28
PL324746A1 (en) 1998-06-08
TR199800146T1 (xx) 1998-06-22
NO980380D0 (no) 1998-01-28
NO980380L (no) 1998-03-16
EA000534B1 (ru) 1999-10-28
NZ329649A (en) 1998-11-25
DE69725696T2 (de) 2004-07-29
SK284359B6 (sk) 2005-02-04
JP2009084284A (ja) 2009-04-23
ES2208907T3 (es) 2004-06-16

Similar Documents

Publication Publication Date Title
YU4198A (sh) Karbapenem antibiotik, kompozicija i postupak za dobijanje
MY115662A (en) Novel compounds with analgesic effect
MY132705A (en) Novel compounds with analgesic effect
CA2274074A1 (en) Novel compounds with analgesic effect
AU6645998A (en) Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
NZ325837A (en) Carbamoyloxy derivatives of mutiline and their use as antibacterials
AU5727899A (en) Diaminocyclobutene-3,4-dione derivatives, their preparation and use
ZA974573B (en) Carbapenem antibiotic, composition and method of preparation.
SE9504662D0 (sv) New compounds
AP9801235A0 (en) Erythromycin derivatives.
MY116202A (en) Carbapenem antibiotic, composition and method of preparation
ECSP972136A (es) Composicion y metodo de preparacion de un antibiotico de carbapemen
GR920100423A (el) Ανταγωνιστές 5-ΗΤ4 κινολιζιδινυλ εστέρος.